Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Oct 31, 2025 | (Q1)Jul 31, 2025 | (FY)Apr 30, 2025 | (Q4)Apr 30, 2025 | (Q3)Jan 31, 2025 | (Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9.93%234.93M | 12.92%203.72M | 11.06%789.46M | 5.37%191.91M | 2.53%662.99M | -67.96%213.71M | -65.09%180.41M | -7.03%710.81M | 116.99%182.12M | -5.08%646.66M |
| Cost of revenue | -0.18%154.49M | 5.35%137.61M | 4.98%565.48M | -1.21%134.93M | 3.22%547.13M | -70.88%154.77M | -68.02%130.62M | -4.36%538.66M | 117.41%136.58M | 0.19%530.04M |
| Gross profit | 36.47%80.44M | 32.79%66.11M | 30.10%223.97M | 25.10%56.98M | -0.65%115.86M | -56.51%58.94M | -54.02%49.79M | -14.51%172.15M | 115.82%45.54M | -23.37%116.62M |
| Operating expense | 17.18%35.45M | 26.62%30.2M | -23.38%77.3M | 28.62%34.57M | -0.23%93.6M | -66.91%30.25M | -70.86%23.85M | -8.93%100.9M | 116.04%26.88M | -1.20%93.81M |
| Staff costs | ---- | ---- | ---- | ---- | ---- | 46.10%16.53M | ---- | ---- | ---- | ---- |
| Selling and administrative expenses | 22.67%34.71M | 28.90%30.31M | 12.31%112.44M | 23.69%32.22M | 1.50%94.3M | -63.47%28.29M | -71.49%23.51M | -12.30%100.11M | 115.83%26.05M | -0.66%92.9M |
| -Selling and marketing expense | 19.77%22.26M | 22.68%19.33M | 13.49%70.78M | 25.38%18.8M | -6.44%53.83M | -70.22%18.59M | -67.69%15.76M | -17.10%62.37M | 114.77%14.99M | -6.42%57.54M |
| -General and administrative expense | 28.22%12.45M | 41.51%10.98M | 10.38%41.66M | 21.39%13.42M | 14.42%40.46M | -35.49%9.71M | -76.98%7.76M | -3.02%37.74M | 117.55%11.06M | 10.41%35.36M |
| Research and development costs | ---- | ---- | ---- | ---- | ---- | 19.86%169K | ---- | ---- | ---- | ---- |
| Other operating expenses | -62.12%742K | ---- | -4,570.23%-35.14M | 183.15%2.35M | -176.98%-699K | -22.39%1.96M | --342K | 123.39%786K | --831K | -36.37%908K |
| Total other operating income | ---- | --103K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 56.81%44.99M | 38.46%35.91M | 105.84%146.67M | 20.04%22.41M | -2.38%22.27M | -34.92%28.69M | -1.91%25.94M | -21.34%71.25M | 115.52%18.67M | -60.16%22.81M |
| Net non-operating interest income expense | 15.60%-17.96M | 3.52%-18.9M | -2.64%-79.23M | 7.73%-19.09M | -25.65%-66.03M | 56.51%-21.28M | 55.31%-19.59M | -56.07%-77.2M | -118.64%-20.69M | -42.09%-52.55M |
| Non-operating interest income | 79.43%314K | -21.76%151K | -33.12%103K | -53.52%152K | -31.16%137K | -43.55%175K | -5.85%193K | 75.00%154K | 150.62%327K | -11.95%199K |
| Non-operating interest expense | -14.83%18.27M | -3.70%19.05M | 2.21%79.9M | -8.44%19.24M | 25.43%66.17M | -56.43%21.46M | -55.08%19.78M | 55.32%78.18M | 118.96%21.02M | 41.76%52.75M |
| Total other finance cost | ---- | ---- | 31.64%-566K | ---- | ---- | ---- | ---- | -5.61%-828K | ---- | ---- |
| Net investment income | -17,891.67%-2.16M | -385.06%-5.52M | -215.27%-1.16M | 196.88%1.14M | -107.82%-4.33M | 93.91%-12K | -122.81%-1.14M | 3.51%1M | 113.05%384K | -225.98%-2.09M |
| Gain/Loss on financial instruments designated as cash flow hedges | 1,385.08%11.05M | |||||||||
| Gain/Loss on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -640.00%-54K | -410.17%-1.51M | 63.28%-390K | 461.15%567K | -19.79%-672K | 102.09%10K | -320.15%-295K | 28.53%-1.06M | 85.77%-157K | -66.47%-561K |
| Special income /charges | ||||||||||
| Other non-operating income /expenses | ||||||||||
| Income before tax | 234.99%24.82M | 103.19%9.99M | 1,197.44%65.89M | 379.47%5.02M | -50.57%-48.77M | 234.08%7.41M | 140.08%4.92M | -114.79%-6M | 86.55%-1.8M | -250.15%-32.39M |
| Income tax | 56.44%7.98M | -1.56%4.48M | 21.32%17.03M | -114.56%-674K | -207.42%-10.07M | 172.89%5.1M | 17,611.54%4.55M | -22.95%14.04M | 246.67%4.63M | -137.59%-3.28M |
| Net income | 170.12%16.83M | 114.99%5.51M | -539.27%-843.51M | -839.99%-782.08M | -32.92%-38.7M | -224.64%-24.01M | -200.16%-36.73M | -619.96%-131.95M | -611.42%-83.2M | -326.45%-29.12M |
| Net income continuous operations | 630.28%16.83M | 1,417.08%5.51M | 343.75%48.86M | 188.65%5.7M | -32.92%-38.7M | 131.17%2.31M | 102.97%363K | -189.58%-20.04M | 56.28%-6.43M | -326.45%-29.12M |
| Net income discontinuous operations | --0 | --0 | -697.44%-892.37M | -926.08%-787.78M | ---- | ---26.31M | ---37.1M | -3,828.92%-111.91M | ---76.78M | ---- |
| Noncontrolling interests | 0 | 0 | -1,588.11%-47.13M | -763.29%-39.93M | -2,513.08%-2.8M | -268.55%-1.85M | -403.68%-2.56M | -133.13%-2.79M | -2,345.15%-4.63M | -103.56%-107K |
| Net income attributable to the company | 175.97%16.83M | 116.12%5.51M | -516.60%-796.38M | -844.51%-742.16M | -23.77%-35.9M | -160.93%-22.16M | -161.24%-34.17M | -862.03%-129.16M | -560.25%-78.58M | -394.53%-29.01M |
| Preferred stock dividends | 0 | 0 | ||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 175.97%16.83M | 116.12%5.51M | -516.60%-796.38M | -844.51%-742.16M | -23.77%-35.9M | -160.93%-22.16M | -161.24%-34.17M | -1,102.30%-129.16M | -392.21%-78.58M | -394.53%-29.01M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 625.00%0.0087 | 1,300.00%0.0028 | -517.02%-0.4097 | -845.05%-0.3818 | -24.16%-0.0185 | 127.27%0.0012 | 102.99%0.0002 | -1,106.06%-0.0664 | -551.61%-0.0404 | -423.91%-0.0149 |
| Diluted earnings per share | 625.00%0.0087 | 1,300.00%0.0028 | -517.02%-0.4097 | -845.05%-0.3818 | -24.16%-0.0185 | 127.27%0.0012 | 102.99%0.0002 | -1,106.06%-0.0664 | -551.61%-0.0404 | -423.91%-0.0149 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -92.43%0.0013 | 0 | 0 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |